| TTM
|
6/30/2026
|
6/30/2025
|
6/30/2024
|
6/30/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,566,637 | 3,274,162 | 2,573,545 | 1,928,490 | 1,940,512 |
|
Cost of Revenue
|
-1,907,324 | -1,762,788 | -1,456,094 | -1,188,728 | -1,179,781 |
|
Gross Profit
|
1,659,313 | 1,511,374 | 1,117,451 | 739,762 | 760,731 |
|
Selling, General and Administrative Expenses
|
-135,262 | -121,766 | -111,499 | -80,997 | -70,993 |
|
Research and Development Expenses
|
-208,863 | -204,166 | -169,672 | -159,768 | -145,172 |
|
Operating Income/Expenses
|
-344,125 | -325,932 | -281,171 | -240,765 | -216,165 |
|
Total Operating Profit/Loss
|
1,315,188 | 1,185,442 | 836,280 | 498,997 | 544,566 |
| Total Net Finance Income/Expense
|
6,976 | -2,367 | -30,628 | -75,169 | -58,224 |
|
Non-Operating Income/Expenses, Total
|
6,976 | -2,367 | -30,628 | -75,169 | -58,224 |
|
Pretax Income
|
1,322,164 | 1,183,075 | 805,652 | 423,828 | 486,342 |
|
Provision for Income Tax
|
-249,273 | -222,772 | -93,730 | -73,868 | -78,701 |
|
Net Income from Continuing Operations
|
1,072,891 | 960,303 | 711,922 | 349,960 | 407,641 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,072,891 | 960,303 | 711,922 | 349,960 | 407,641 |
|
Net Income after Non-Controlling/Minority Interests
|
1,072,891 | 960,303 | 711,922 | 349,960 | 407,641 |
|
Net Income Available to Common Stockholders
|
1,072,891 | 960,303 | 711,922 | 349,960 | 407,641 |
|
Diluted Net Income Available to Common Stockholders
|
1,072,891 | 960,303 | 711,922 | 349,960 | 407,641 |
|
Common Dividend per Share
|
3.20 | 3.20 | 2.40 | 2.40 | 2.40 |
| Basic EPS
|
17.73 | 15.87 | 11.77 | 5.79 | 6.75 |
| Diluted EPS
|
17.71 | 15.85 | 11.76 | 5.79 | 6.74 |
|
Basic Weighted Average Shares Outstanding
|
60,516.25 | 60,510 | 60,480 | 60,454 | 60,435 |
|
Diluted Weighted Average Shares Outstanding
|
60,571.25 | 60,570 | 60,534 | 60,458 | 60,451 |
|
Reported Normalized Diluted EPS
|
15.95 | 15.95 | 10.96 | 5.87 | 6.80 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,315,188 | 1,185,442 | 836,280 | 498,997 | 544,566 |
|
EBITDA
|
1,334,169 | 1,204,386 | 858,181 | 518,248 | 560,858 |
|
Normalized EBITDA
|
1,341,750 | 1,211,830 | 865,389 | 524,606 | 565,592 |
|
Normalized Income
|
1,079,042.72 | 965,970 | 663,690 | 354,758 | 411,243 |
|
Total Unusual Items
|
7,581 | 7,444 | 7,208 | 6,358 | 4,734 |
|
Total Unusual Items Excluding Goodwill
|
7,581 | 7,444 | 7,208 | 6,358 | 4,734 |
|
Tax Effect of Unusual Items
|
1,429.28 | 1,399.47 | 836.13 | 1,106.29 | 766.91 |
6/30/2023 - 10/14/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade